109 related articles for article (PubMed ID: 3496281)
1. Immunological effects of ciclosporin in primary biliary cirrhosis: suppression of activated T cells and autoantibody levels.
Karlsson-Parra A; Tötterman TH; Nyberg A; Mendel-Hartvig I; Lööf L; Forsum U
Int Arch Allergy Appl Immunol; 1987; 83(3):256-64. PubMed ID: 3496281
[TBL] [Abstract][Full Text] [Related]
2. [Infiltrating T-cells in primary biliary cirrhosis recognize mitochondrial epitopes].
Löhr H; Fleischer B; Gerken G; Meyer zum Büschenfelde KH; Manns M
Z Gastroenterol; 1993 Feb; 31 Suppl 2():99-103. PubMed ID: 7483731
[TBL] [Abstract][Full Text] [Related]
3. Antimitochondrial antibody-negative primary biliary cirrhosis: a subset of primary biliary cirrhosis.
Liu B; Shi XH; Zhang FC; Zhang W; Gao LX
Liver Int; 2008 Feb; 28(2):233-9. PubMed ID: 18251980
[TBL] [Abstract][Full Text] [Related]
4. The predictive value of antimitochondrial antibodies in establishing the diagnosis of primary biliary cirrhosis.
Hasselström K; Nilsson LA; Wallerstedt S
Scand J Gastroenterol; 1988 Jan; 23(1):103-6. PubMed ID: 3344395
[TBL] [Abstract][Full Text] [Related]
5. Primary biliary cirrhosis. High proportions of B cells in blood and liver tissue produce anti-mitochondrial antibodies of several Ig classes.
Björkland A; Lööf L; Mendel-Hartvig I; Tötterman TH
J Immunol; 1994 Sep; 153(6):2750-7. PubMed ID: 8077679
[TBL] [Abstract][Full Text] [Related]
6. Effects of cyclosporin A on suppressor and inducer T lymphocytes in primary biliary cirrhosis.
Routhier G; Epstein O; Janossy G; Thomas HC; Sherlock ; Kung PC; Goldstein G
Lancet; 1980 Dec; 2(8206):1223-6. PubMed ID: 6108396
[TBL] [Abstract][Full Text] [Related]
7. [Immunological characteristics of primary biliary cirrhosis patients].
Yan HP; Zhuang H; Liu YM; Feng X; Tan YF; Liu Y; Zhang X; Zhao CH
Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):12-6. PubMed ID: 15670483
[TBL] [Abstract][Full Text] [Related]
8. Primary biliary cirrhosis--a revised clinical spectrum.
James O; Macklon AF; Watson AJ
Lancet; 1981 Jun; 1(8233):1278-81. PubMed ID: 6112603
[TBL] [Abstract][Full Text] [Related]
9. [The value of antimitochondrial antibody and its subtypes in the diagnosis of primary biliary cirrhosis].
Yao DK; Xie WF; Chen WZ; Liu HY; Tu XQ; Fan LY
Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):9-11. PubMed ID: 15670482
[TBL] [Abstract][Full Text] [Related]
10. Immunological studies in familial primary biliary cirrhosis.
Tong MJ; Nies KM; Reynolds TB; Quismorio FP
Gastroenterology; 1976 Aug; 71(2):305-7. PubMed ID: 1084842
[TBL] [Abstract][Full Text] [Related]
11. Increased numbers of circulating ICOS⁺ follicular helper T and CD38⁺ plasma cells in patients with newly diagnosed primary biliary cirrhosis.
Wang L; Sun X; Qiu J; Cai Y; Ma L; Zhao P; Jiang Y
Dig Dis Sci; 2015 Feb; 60(2):405-13. PubMed ID: 25404409
[TBL] [Abstract][Full Text] [Related]
12. No prognostic significance of antimitochondrial antibody profile testing in primary biliary cirrhosis.
Vleggaar FP; van Buuren HR
Hepatogastroenterology; 2004; 51(58):937-40. PubMed ID: 15239218
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a new mitochondrial antigen-antibody system (M9/anti-M9) in patients with anti-M2 positive and anti-M2 negative primary biliary cirrhosis.
Klein R; Berg PA
Clin Exp Immunol; 1988 Oct; 74(1):68-74. PubMed ID: 2464450
[TBL] [Abstract][Full Text] [Related]
14. In vitro production of antimitochondrial antibody by peripheral blood mononuclear cells in patients with primary biliary cirrhosis.
Ishikawa T; Kakumu S; Wakita T; Takayanagi M; Yoshioka K
J Clin Lab Immunol; 1991 May; 35(1):17-25. PubMed ID: 1668286
[TBL] [Abstract][Full Text] [Related]
15. Primary biliary cirrhosis in antimitochondrial antibody-negative patients: Chang Gung Memorial Hospital experience.
Tsou YK; Yeh CT
Chang Gung Med J; 2003 May; 26(5):323-9. PubMed ID: 12934848
[TBL] [Abstract][Full Text] [Related]
16. T lymphocyte subsets in the peripheral blood in patients with primary biliary cirrhosis.
Shin T; Mizoguchi Y; Kawada N; Kobayashi K
Arerugi; 1989 Jun; 38(6):501-7. PubMed ID: 2589983
[TBL] [Abstract][Full Text] [Related]
17. [Clinical significance of antimitochondrial antibodies].
Rüegg R; Matter L; Schopfer K; Grob PJ
Schweiz Med Wochenschr; 1985 Mar; 115(9):290-6. PubMed ID: 3983600
[TBL] [Abstract][Full Text] [Related]
18. Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation.
Kim WR; Poterucha JJ; Jorgensen RA; Batts KP; Homburger HA; Dickson ER; Krom RA; Wiesner RH; Lindor KD
Hepatology; 1997 Jul; 26(1):22-6. PubMed ID: 9214447
[TBL] [Abstract][Full Text] [Related]
19. Evidence for a locally driven mucosal response and the presence of mitochondrial antigens in saliva in primary biliary cirrhosis.
Reynoso-Paz S; Leung PS; Van De Water J; Tanaka A; Munoz S; Bass N; Lindor K; Donald PJ; Coppel RL; Ansari AA; Gershwin ME
Hepatology; 2000 Jan; 31(1):24-9. PubMed ID: 10613723
[TBL] [Abstract][Full Text] [Related]
20. Treatment of pure red cell aplasia with ciclosporin: suppression of activated T suppressor/cytotoxic and NK-like cells in marrow and blood correlates with haematological response.
Tötterman TH; Bengtsson M
Eur J Haematol; 1988 Sep; 41(3):204-11. PubMed ID: 3141208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
